A Year of Firsts for Alzheimer’s Blood Testing
With the first FDA-cleared test and clinical guidelines debuting since May 2025, labs are evaluating how blood-based biomarkers fit into diagnostic protocols.
Latest Articles
Editor's Top Picks
House Committee Approves $5 Million to Improve Pediatric Lab Testing
The funding, allocated to the Centers for Disease Control and Prevention, aims to establish more accurate normal ranges for children’s medical results.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Seegene Launches New Test for Multidrug-Resistant Organisms in Europe
The assay is CE marked under the European Union In Vitro Diagnostic Regulation and identifies resistance genes to help prevent hospital-acquired infections.
Equipment & Supply Spotlight
MGI Tech Unveils New Laboratory Automation and Proteomics Solutions
The company introduced systems for single-cell proteomics, clinical sample processing, and spatial proteomics.
News, Know-How & Standards
Disease Detection & Understanding
Blood-Based Lung Cancer Assay Matches CT Sensitivity in NLST Evaluation
In studies using National Lung Screening Trial biospecimens, a liquid biopsy assay showed similar sensitivity to low-dose CT screening and detected cancers missed by imaging.
